Back
Also listed as
RYLPF
OTC
Day Range
$26.61
$26.98
52-Week Range
$21.48
$33.44
Volume
1,377,237
50D / 200D Avg
$29.77
/
$27.47
Prev Close
$26.81
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 28.6 | 0.4 |
| P/B | 2.3 | 2.9 |
| ROE % | 7.8 | 3.7 |
| Net Margin % | 5.0 | 3.9 |
| Rev Growth 5Y % | 1.0 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.27
$2.18 – $2.44
|
21 B | 1 |
| FY2029 |
$2.04
$1.95 – $2.20
|
21 B | 1 |
| FY2028 |
$1.94
$1.86 – $2.09
|
20 B | 1 |
Key Takeaways
Revenue grew 0.97% annually over 5 years — modest growth
Generating 893.00M in free cash flow
Cash machine — converts 99.78% of earnings into free cash flow
Capital efficient — spends only 1.51% of revenue on capex
Growth
Revenue Growth (5Y)
0.97%
Revenue (1Y)-1.04%
Earnings (1Y)N/A
FCF Growth (3Y)-32.11%
Quality
Return on Equity
7.80%
ROIC5.61%
Net Margin5.02%
Op. Margin7.98%
Safety
Debt / Equity
0.74
Current Ratio1.32
Interest Coverage4.28
Valuation
P/E Ratio
28.63
P/B Ratio2.34
EV/EBITDA21.71
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.04% | Revenue Growth (3Y) | -0.93% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 0.97% | Earnings Growth (5Y) | -27.94% |
| Profitability | |||
| Revenue (TTM) | 17.83B | Net Income (TTM) | 895.00M |
| ROE | 7.80% | ROA | 3.32% |
| Gross Margin | 45.18% | Operating Margin | 7.98% |
| Net Margin | 5.02% | Free Cash Flow (TTM) | 893.00M |
| ROIC | 5.61% | FCF Growth (3Y) | -32.11% |
| Safety | |||
| Debt / Equity | 0.74 | Current Ratio | 1.32 |
| Interest Coverage | 4.28 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 28.63 | P/B Ratio | 2.34 |
| P/S Ratio | 1.44 | PEG Ratio | -0.11 |
| EV/EBITDA | 21.71 | Dividend Yield | 0.01% |
| Market Cap | 25.62B | Enterprise Value | 30.92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17.83B | 18.02B | 18.17B | 17.83B | 17.16B |
| Net Income | 895.00M | -702.00M | -466.00M | -1.61B | 3.32B |
| EPS (Diluted) | 0.93 | -0.75 | -0.49 | -1.68 | 0.64 |
| Gross Profit | 8.06B | 7.77B | 7.45B | 7.19B | 7.17B |
| Operating Income | 1.42B | 529.00M | -115.00M | -1.53B | 553.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 26.94B | 28.98B | 29.41B | 30.69B | 30.96B |
| Total Liabilities | 15.96B | 16.93B | 17.35B | 17.41B | 16.49B |
| Shareholders' Equity | 10.96B | 12.01B | 12.03B | 13.25B | 14.44B |
| Total Debt | 8.09B | 7.49B | 7.29B | 7.34B | 6.05B |
| Cash & Equivalents | 2.79B | 2.40B | 1.87B | 1.17B | 2.30B |
| Current Assets | 9.93B | 10.02B | 9.94B | 10.26B | 10.35B |
| Current Liabilities | 7.51B | 8.14B | 8.29B | 7.93B | 7.45B |